X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865310/0/en/BiomX-Announces-the-Appointment-of-Susan-Blum-to-its-Board-of-Directors.html
https://www.biospace.com/article/releases/biomx-announces-compliance-with-nyse-guidelines-on-audit-opinion-disclosure/
https://www.globenewswire.com/news-release/2024/04/03/2856746/0/en/BiomX-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/27/2852992/0/en/BiomX-to-Host-Fourth-Quarter-and-Full-Year-2023-Financial-Results-Conference-Call-and-Webcast-on-April-3rd-2024.html
https://www.globenewswire.com/news-release/2024/03/18/2847627/0/en/BiomX-Announces-Closing-of-the-Acquisition-of-Adaptive-Phage-Therapeutics-and-Concurrent-50-Million-Financing.html
https://www.globenewswire.com//news-release/2024/03/06/2841300/0/en/BiomX-Announces-Entry-into-Merger-Agreement-with-Adaptive-Phage-Therapeutics-and-Concurrent-50-Million-Financing.html
https://www.fiercebiotech.com/biotech/biomx-acquires-fellow-bacteria-killing-virus-company-apt-accelerate-phase-2-plans
https://www.globenewswire.com//news-release/2024/01/04/2803947/0/en/BiomX-Receives-Orphan-Drug-Designation-from-the-U-S-Food-and-Drug-Administration-for-BX004-for-the-Treatment-of-Chronic-Pulmonary-Infection-Caused-by-Pseudomonas-aeruginosa-in-Pati.html
https://www.globenewswire.com//news-release/2023/11/30/2788960/0/en/BiomX-to-Host-Virtual-Key-Opinion-Leader-KOL-Event-to-Review-the-Positive-Results-from-Part-2-of-Phase-1b-2a-Trial-of-BX004-in-Cystic-Fibrosis-Patients-with-Chronic-Pseudomonas-aer.html
https://www.globenewswire.com//news-release/2023/11/29/2787575/0/en/BiomX-Announces-Positive-Topline-Results-from-Part-2-of-the-Phase-1b-2a-Trial-Evaluating-BX004-for-Treatment-of-Chronic-Pulmonary-Infections-in-Patients-with-Cystic-Fibrosis.html
Market Place
Share 
